Liu et al. found that low SPARC expression levels were associated with aggressive features in patients, such as bowel wall invasion, high carcinoembryonic antigen and Glucose polypeptide antigen 19-9 levels, and lymph node metastasis 24. Here, SPARC is linked to metastatic malignant neoplasm in the lymph nodes.